Search clinical trials for: eribulin mesilate
Total 272 results
-
Shanghai Yizhong Pharmaceutical Co., Ltd.RecruitingMetastatic Breast Cancer (MBC)China
-
Eisai Inc.CompletedEwing Sarcoma | Rhabdomyosarcoma | Refractory or Recurrent Solid Tumors | Non-Rhabdomyosarcoma Soft Tissue SarcomaSpain, United Kingdom, Italy, France, Germany, Greece, Poland, Switzerland
-
Swiss Group for Clinical Cancer ResearchTerminatedAdenocarcinoma | Breast CancerSwitzerland
-
Eisai LimitedCompleted
-
Hansoh BioMedical R&D CompanyNot yet recruitingNon-Squamous Non-Small Cell Lung Cancer
-
Harbin Medical UniversityNot yet recruiting
-
Fudan UniversityRecruitingTNBC - Triple-Negative Breast CancerChina
-
Shanghai Escugen Biotechnology Co., LtdNot yet recruitingMetastatic Breast CancerChina
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not yet recruiting
-
Fudan UniversityNot yet recruitingTriple-negative Breast Cancer
-
Fudan UniversityNot yet recruitingTriple-negative Breast Cancer
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not yet recruiting
-
Enliven TherapeuticsRecruitingColorectal Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2 Amplification | HER2 Positive Solid TumorsUnited States
-
Walton Centre NHS Foundation TrustUniversity of Liverpool; National Institute for Health Research, United KingdomNot yet recruitingTiming to Restart Direct Oral Anticoagulants After Traumatic Intracranial Haemorrhage (RESTARTtlCrH)Traumatic Intracranial Haemorrhage
-
Zhejiang Cancer HospitalNot yet recruiting
-
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Not yet recruitingTriple Negative Breast CancerChina
-
Xiaotong HouNot yet recruitingExtracorporeal Membrane Oxygenation ComplicationChina
-
Sun Yat-sen UniversityRecruitingBreast Cancer | Refractory Breast CarcinomaChina
-
Intensity Therapeutics, Inc.Premier Research Group plcNot yet recruiting
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruiting
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingMetastatic Breast Cancer | Advanced Malignancies | Recurrent Breast CancerChina
-
Shengjing HospitalNot yet recruitingTriple Negative Breast CancerChina
-
Guangdong Provincial People's HospitalSun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Shantou...RecruitingAdvanced Breast Cancer | HER2-negative Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.; Corcept Therapeutics; Breast Cancer Research FoundationRecruitingMetastatic Breast CancerUnited States
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruiting
-
Sichuan Kelun Pharmaceutical Research Institute...Not yet recruitingMetastatic Breast Cancer
-
Xu LiLanZhou University; The Affiliated Nanjing Drum Tower Hospital of Nanjing University... and other collaboratorsNot yet recruitingSepsis | Sepsis-induced Coagulopathy | Nafamostat Mesilate
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdNot yet recruiting
-
M.D. Anderson Cancer CenterRecruitingRefractory Solid TumorsUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
MedSIRMenarini GroupRecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast CancerSpain
-
Fudan UniversityRecruitingTriple-Negative Breast CancerChina
-
University of Heidelberg Medical CenterSanofi; KKS Netzwerk; Deutsche Studiengruppe Multiples Myelom (DSMM)Recruiting
-
Regina Elena Cancer InstituteUniversity of Pisa; University of Roma La Sapienza; University of Turin, Italy; Istituto Oncologico Veneto IRCCS and other collaboratorsRecruitingDifferentiated Thyroid Cancer | GenderItaly
-
Fudan UniversityRecruitingTriple-Negative Breast CancerChina
-
Australia New Zealand Gynaecological Oncology GroupMerck Sharp & Dohme LLC; Eisai Inc.RecruitingUterine Carcinosarcoma | Ovarian CarcinosarcomaCanada, Australia, United Kingdom
-
Memorial Sloan Kettering Cancer CenterSynDevRx, Inc.RecruitingBreast Cancer | Metastatic Triple-Negative Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Seoul National University HospitalRecruitingAdvanced Breast CancerKorea, Republic of
-
Beijing 302 HospitalRecruitingTNBC - Triple-Negative Breast CancerChina
-
First Affiliated Hospital Xi'an Jiaotong UniversitySecond Affiliated Hospital of Xi'an Jiaotong University; Tang-Du Hospital; Shangluo... and other collaboratorsNot yet recruitingHemorrhage | Trauma | AKI | Sepsis Syndrome | Thrombus | MODSChina
-
AstraZenecaDaiichi SankyoRecruitingBreast CancerUnited States, Spain, United Kingdom, Korea, Republic of, Philippines, Canada, Germany, Italy, Poland, Belgium, Mexico, Japan, France, Brazil, Taiwan, Thailand, Hungary, Turkey, China, India, South Africa, Singapore, Argentina
-
Henan Cancer HospitalRecruitingHR Positive HER2 Negative Advanced Breast CancerChina
-
University of Milano BicoccaEISAI s.r.l.RecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast CancerItaly
-
Elizabeth K. Lee MDMerck Sharp & Dohme LLCRecruitingGynecologic Cancer | Ovarian Clear Cell CarcinomaUnited States
-
Fifth Affiliated Hospital, Sun Yat-Sen UniversityNot yet recruiting
-
Institut fuer FrauengesundheitEisai GmbHRecruitingAssessing ImmunoResponse Post Eribulin: Eribulin and Immunogenicity in Advanced Breast Cancer (AIRE)Breast Cancer Female | Breast Cancer Metastatic | Neoplasm, BreastGermany